|
|
|
Volumn 4, Issue 3, 1997, Pages 231-238
|
|
The role of hemopoietic growth factors in the treatment of myelodysplastic syndromes
|
|
Author keywords
Colony stimulating factors; Cytokines; Erythropoietin; Myelodysplastic syndrome
|
|
Indexed keywords
CYTARABINE;
ERYTHROPOIETIN;
GRANULOCYTE COLONY STIMULATING FACTOR;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
HEMOPOIETIC GROWTH FACTOR;
INTERLEUKIN 3;
INTERLEUKIN 6;
RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
ACUTE GRANULOCYTIC LEUKEMIA;
ANEMIA;
BONE PAIN;
CANCER GROWTH;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CYTOPENIA;
DRUG POTENTIATION;
FLU LIKE SYNDROME;
HIGH RISK PATIENT;
HUMAN;
LEUKOCYTOSIS;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
MYELODYSPLASTIC SYNDROME;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRELEUKEMIA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
SUBCUTANEOUS DRUG ADMINISTRATION;
THROMBOCYTOPENIA;
|
|
EID: 0030688002
PISSN: 10702903
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (8)
|
|
References (47)
|
